Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment.
Bravo-Perez C, Guarnera L, Williams ND, Visconte V.
Medicina (Kaunas). 2023 Sep 6;59(9):1612. doi: 10.3390/medicina59091612.
Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study.
Jang JH, Wong L, Ko BS, Yoon SS, Li K, Baltcheva I, Nidamarthy PK, Chawla R, Junge G, Yap ES.
Blood Adv. 2022 Aug 9;6(15):4450-4460. doi: 10.1182/bloodadvances.2022006960.
[Paroxysmal nocturnal hemoglobinuria].
Peffault de Latour R, Socié G.
Rev Prat. 2007 Apr 15;57(7):701-3.
Paroxysmal nocturnal hemoglobinuria.
Rotoli B, Luzzatto L.
Semin Hematol. 1989 Jul;26(3):201-7.
Paroxysmal nocturnal hemoglobinuria clone in a patient with acute promyelocytic leukemia.
Singh B, Khan N, Kaur P, Maroules M.
J Cancer Res Ther. 2022 Jan-Mar;18(1):294-296. doi: 10.4103/jcrt.JCRT_1176_19.
Iptacopan (Fabhalta) for paroxysmal nocturnal hemoglobinuria.
[No authors listed]
Med Lett Drugs Ther. 2024 Sep 30;66(1712):e171-e173. doi: 10.58347/tml.2024.1712e.
Progress in the Management of Pregnancy with Paroxysmal Nocturnal Hemoglobinuria: A Review.
Zhang B, Chu R, Huang C, Song X, Wang J, Li L, Xu Y, Ma Y.
J Womens Health (Larchmt). 2024 Jan;33(1):98-104. doi: 10.1089/jwh.2023.0164. Epub 2023 Nov 2.
[Management of paroxysmal nocturnal hemoglobinuria: an update].
Kawaguchi T.
Rinsho Ketsueki. 2018;59(6):703-710. doi: 10.11406/rinketsu.59.703.
Real-world experience of pegcetacoplan in paroxysmal nocturnal hemoglobinuria.
Griffin M, Kelly R, Brindel I, Maafa L, Trikha R, Muus P, Munir T, Varghese AM, Mitchell L, Nagumantry S, Gandhi S, Pike A, Kulasekararaj AG, Peffault de Latour R.
Am J Hematol. 2024 May;99(5):816-823. doi: 10.1002/ajh.27242. Epub 2024 Feb 13.
Paroxysmal nocturnal hemoglobinuria without GPI-anchor deficiency.
Brodsky RA.
J Clin Invest. 2019 Dec 2;129(12):5074-5076. doi: 10.1172/JCI131647.
